Faculty Collaboration Database

Cindy L. Schwartz MD, MPH

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Pediatrics Hematology Oncology Blood and Marrow Transplant

Member of the Cancer Center

I am willing to collaborate on research projects.
I am willing to mentor a junior faculty member.

Send Message

Request Meeting

View Curriculum Vitae

Publications (153)

Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials (Heneghan MB, Renfro LA, Wu Y, Crisler KM, Marcotte E, Trippett T, Horton T, Hoppe BS, Keller FG, Forlenza C, Schwartz C, Kelly KM, Cole PD, Castellino SM, Kahn JM) Pediatric Blood and Cancer September 2026;73(9) SCOPUS ID: 2-s2.0-105045485479 09/01/2026

Erratum: Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2. (Mobley EM, Doody DR, Colan SD, Aggarwal S, Aplenc R, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Chow EJ, Lipshultz SE) J Clin Oncol 2026 Oct;44(28):2756 PMID: 42636420 SCOPUS ID: 2-s2.0-105049604845 08/24/2026

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2. (Mobley EM, Doody DR, Colan SD, Aggarwal S, Aplenc R, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Chow EJ, Lipshultz SE) J Clin Oncol 2026 Oct;44(28):2680-2689 PMID: 42561216 SCOPUS ID: 2-s2.0-105047458984 08/06/2026

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High-Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331. (Belsky JA, Renfro LA, Keller FG, Hodgson DC, Punnett A, McCarten K, Cho SY, Wu Y, Kelly KM, Castellino SM, Schwartz CL) Pediatr Blood Cancer 2025 Sep;72(9):e31856 PMID: 40515508 PMCID: PMC12230980 SCOPUS ID: 2-s2.0-105008189726 06/14/2025 1 Citation

PET Response and Outcome in Low-Risk Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1. (Marks LJ, Wu Y, McCarten KM, Renfro LA, Pei Q, Kelly KM, Schwartz CL, Castellino SM, Appel BE) Pediatr Blood Cancer 2025 May;72(5):e31606 PMID: 39953678 PMCID: PMC11934935 SCOPUS ID: 2-s2.0-85217793800 02/15/2025 4 Citations

Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial. (Hoppe BS, Milgrom SA, Renfro LA, Wu Y, Schwartz CL, Constine LS, McCarten KM, Kelly KM, Hodgson D, Castellino SM, Keller FG) JAMA Oncol 2025 Mar 01;11(3):340-342 PMID: 39745710 PMCID: PMC11837869 SCOPUS ID: 2-s2.0-85215849891 01/02/2025 7 Citations

Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). (Becktell K, Chen Y, Yasui Y, Phelan R, Armstrong GT, Link M, Oeffinger K, Snyder C, Daw N, Weil B, Weldon C, Chow EJ, Schwartz CL) Pediatr Blood Cancer 2024 Oct;71(10):e31189 PMID: 39010279 PMCID: PMC11343645 SCOPUS ID: 2-s2.0-85198547860 07/16/2024 5 Citations

Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. (Lo AC, Liu A, Liu Q, Yasui Y, Castellino SM, Kelly KM, Hererra AF, Friedberg JW, Friedman DL, Schwartz CL, Pei Q, Kessel S, Bergeron-Gravel S, Dama H, Roberts K, Constine LS, Hodgson DC) JAMA Netw Open 2024 Jan 02;7(1):e2351062 PMID: 38241048 PMCID: PMC10799264 SCOPUS ID: 2-s2.0-85182840954 01/19/2024 17 Citations

Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study. (Phadnis S, Wang X, Daw NC, Herzog CE, Subbiah IM, Zaky W, Gouda MA, Morani AC, Amini B, Harrison DJ, Piha-Paul SA, Meric-Bernstam F, Gorlick R, Schwartz CL, Subbiah V) ESMO Open 2023 Dec;8(6):101609 PMID: 37879233 PMCID: PMC10774869 SCOPUS ID: 2-s2.0-85174677881 10/26/2023 3 Citations

Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population. (Valencia MC, Hang L, Schmidt D, Nichols J, Zhang J, Yan K, Gonzalez A, Schwartz CL, Phelan R) J Pediatr Hematol Oncol 2023 Jul 01;45(5):e573-e577 PMID: 36898042 SCOPUS ID: 2-s2.0-85163834080 03/11/2023 2 Citations

Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. (Chow EJ, Aggarwal S, Doody DR, Aplenc R, Armenian SH, Baker KS, Bhatia S, Blythe N, Colan SD, Constine LS, Freyer DR, Kopp LM, Laverdière C, Leisenring WM, Sasaki N, Vrooman LM, Asselin BL, Schwartz CL, Lipshultz SE) J Clin Oncol 2023 Apr 20;41(12):2248-2257 PMID: 36669148 PMCID: PMC10448941 SCOPUS ID: 2-s2.0-85152621880 01/21/2023 77 Citations

Post-Traumatic Stress Symptoms in Adolescent Hodgkin Lymphoma Survivors: A Report from Children's Oncology Group AHOD0031. (Werk RS, Koyama T, Sun L, Wolden S, Kelly KM, Constine LS, Schwartz CL, Friedman DL) J Adolesc Young Adult Oncol 2023 Jun;12(3):359-365 PMID: 36094417 PMCID: PMC10282797 SCOPUS ID: 2-s2.0-85149947480 09/13/2022 3 Citations

Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis. (Parekh A, Keller FG, McCarten KM, Kessel S, Cho S, Pei Q, Wu Y, Castellino SM, Constine LS, Schwartz CL, Hodgson D, Kelly KM, Hoppe BS) Blood 2022 Sep 08;140(10):1086-1093 PMID: 35763667 PMCID: PMC9461469 SCOPUS ID: 2-s2.0-85137371565 06/29/2022 13 Citations

Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials. (Kahn JM, Pei Q, Friedman DL, Kaplan J, Keller FG, Hodgson D, Wu Y, Appel BE, Bhatia S, Henderson TO, Schwartz CL, Kelly KM, Castellino SM) Lancet Haematol 2022 Jan;9(1):e49-e57 PMID: 34971582 PMCID: PMC8815096 SCOPUS ID: 2-s2.0-85121687510 01/01/2022 33 Citations

Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group. (Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Schwartz CL, Lipshultz SE, Vrooman LM) Cancer Epidemiol Biomarkers Prev 2022 Mar 01;31(3):536-542 PMID: 34810210 PMCID: PMC9067064 SCOPUS ID: 2-s2.0-85125861487 11/24/2021 32 Citations

Patterns of Initial Relapse from a Phase 3 Study of Response-Based Therapy for High-Risk Hodgkin Lymphoma (AHOD0831): A Report from the Children's Oncology Group. (Parikh RR, Kelly KM, Hodgson DC, Hoppe BS, McCarten KM, Karolczuk K, Pei Q, Wu Y, Cho SY, Schwartz C, Cole PD, Roberts K) Int J Radiat Oncol Biol Phys 2022 Mar 15;112(4):890-900 PMID: 34767937 PMCID: PMC9038118 SCOPUS ID: 2-s2.0-85121755582 11/13/2021 7 Citations

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. (Johnston RL, Mottok A, Chan FC, Jiang A, Diepstra A, Visser L, Telenius A, Gascoyne RD, Friedman DL, Schwartz CL, Kelly KM, Scott DW, Horton TM, Steidl C) Blood 2022 Feb 10;139(6):889-893 PMID: 34662378 PMCID: PMC8832480 SCOPUS ID: 2-s2.0-85124227160 10/19/2021 18 Citations

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group. (Chow EJ, Aplenc R, Vrooman LM, Doody DR, Huang YV, Aggarwal S, Armenian SH, Baker KS, Bhatia S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Asselin BL, Schwartz CL, Lipshultz SE) Cancer 2022 Feb 15;128(4):788-796 PMID: 34644414 PMCID: PMC8792306 SCOPUS ID: 2-s2.0-85116936157 10/14/2021 55 Citations

Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031. (Milgrom SA, Kim J, Chirindel A, Kim J, Pei Q, Chen L, Buxton A, Kessel S, Leal J, McCarten KM, Hoppe BS, Wolden SL, Schwartz CL, Friedman DL, Kelly KM, Cho SY) Pediatr Blood Cancer 2021 Sep;68(9):e29212 PMID: 34245210 PMCID: PMC8809108 SCOPUS ID: 2-s2.0-85110049048 07/11/2021 25 Citations

Pediatric classical Hodgkin lymphoma. (Lo AC, Dieckmann K, Pelz T, Gallop-Evans E, Engenhart-Cabillic R, Vordermark D, Kelly KM, Schwartz CL, Constine LS, Roberts K, Hodgson D) Pediatr Blood Cancer 2021 May;68 Suppl 2:e28562 PMID: 33818890 SCOPUS ID: 2-s2.0-85103854210 04/06/2021 34 Citations

Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group. (Giulino-Roth L, Pei Q, Buxton A, Bush R, Wu Y, Wolden SL, Constine LS, Kelly KM, Schwartz CL, Friedman DL) Blood 2021 Mar 18;137(11):1449-1456 PMID: 33512412 PMCID: PMC7976513 SCOPUS ID: 2-s2.0-85102621700 01/30/2021 25 Citations

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients. (Weisman AJ, Kim J, Lee I, McCarten KM, Kessel S, Schwartz CL, Kelly KM, Jeraj R, Cho SY, Bradshaw TJ) EJNMMI Phys 2020 Dec 14;7(1):76 PMID: 33315178 PMCID: PMC7736382 SCOPUS ID: 2-s2.0-85098602264 12/15/2020 40 Citations

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group. (Kopp LM, Womer RB, Schwartz CL, Ebb DH, Franco VI, Hall D, Barkauskas DA, Krailo MD, Grier HE, Meyers PA, Wexler LH, Marina NM, Janeway KA, Gorlick R, Bernstein ML, Lipshultz SE, Children’s Oncology Group) Cardiooncology 2019;5:15 PMID: 32154021 PMCID: PMC7048050 SCOPUS ID: 2-s2.0-85091180993 03/11/2020 43 Citations

Pediatric hodgkin lymphoma (Hall GW, Schwartz C, Daw S, Constine LS) Hematologic Malignancies 2020:277-296 SCOPUS ID: 2-s2.0-85084235854 01/01/2020

Creating a bridge for transition: From pediatric cancer survival to life-long, risk-based health care of the adult cancer survivor. (Schwartz CL) Cancer 2020 Feb 01;126(3):473-476 PMID: 31626326 SCOPUS ID: 2-s2.0-85074332206 10/19/2019 6 Citations

Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study. (Kahn JM, Kelly KM, Pei Q, Bush R, Friedman DL, Keller FG, Bhatia S, Henderson TO, Schwartz CL, Castellino SM) J Clin Oncol 2019 Nov 10;37(32):3009-3017 PMID: 31539308 PMCID: PMC6839907 SCOPUS ID: 2-s2.0-85074673919 09/21/2019 50 Citations

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group. (Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C) Br J Haematol 2019 Oct;187(1):39-48 PMID: 31180135 PMCID: PMC6857800 SCOPUS ID: 2-s2.0-85067413050 06/11/2019 76 Citations

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. (Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N) Eur J Cancer 2019 Mar;109:36-50 PMID: 30685685 PMCID: PMC6506906 SCOPUS ID: 2-s2.0-85060337012 01/28/2019 610 Citations

Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, Schwartz CL, Friedman DL) Pediatr Blood Cancer 2018 Dec;65(12):e27375 PMID: 30277639 PMCID: PMC6192844 SCOPUS ID: 2-s2.0-85053443891 10/03/2018 11 Citations

Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group. (Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS) Pediatr Blood Cancer 2019 Jan;66(1):e27444 PMID: 30255612 PMCID: PMC6249072 SCOPUS ID: 2-s2.0-85053765635 09/27/2018 47 Citations

Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. (Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Blood 2018 Sep 13;132(11):1208-1211 PMID: 30061157 PMCID: PMC6137557 SCOPUS ID: 2-s2.0-85053144189 08/01/2018 15 Citations

Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031. (McCarten KM, Metzger ML, Drachtman RA, Pei Q, Friedman DL, Schwartz CL, Kelly KM) Pediatr Radiol 2018 Nov;48(12):1736-1744 PMID: 30014200 PMCID: PMC6208959 SCOPUS ID: 2-s2.0-85049956927 07/18/2018 17 Citations

Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. (Keller FG, Castellino SM, Chen L, Pei Q, Voss SD, McCarten KM, Senn SL, Buxton AB, Bush R, Constine LS, Schwartz CL) Cancer 2018 Aug 01;124(15):3210-3219 PMID: 29738613 PMCID: PMC6097921 SCOPUS ID: 2-s2.0-85046551681 05/09/2018 64 Citations

Patterns of Involved-Field Radiation Therapy Protocol Deviations in Pediatric Versus Adolescent and Young Adults With Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD0031. (Parzuchowski A, Bush R, Pei Q, Friedman DL, FitzGerald TJ, Wolden SL, Dharmarajan KV, Constine LS, Laurie F, Kessel SK, Appel B, Fernandez K, Punnett A, Schwartz CL, Cox J, Terezakis SA) Int J Radiat Oncol Biol Phys 2018 Apr 01;100(5):1119-1125 PMID: 29722656 PMCID: PMC6555555 SCOPUS ID: 2-s2.0-85043577610 05/04/2018 6 Citations

Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma. (Aldrink JH, Appel B, Kaplan JA, Hutchison RE, Schwartz CL, Kelly KM, McCarten K, Ehrlich PF) J Pediatr Hematol Oncol 2018 Apr;40(3):246-247 PMID: 29401099 PMCID: PMC5866194 SCOPUS ID: 2-s2.0-85044758727 02/06/2018 1 Citation

Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma. (Welch JJG, Schwartz CL, Higman M, Chen L, Buxton A, Kanakry JA, Kahwash SB, Hutchison RE, Friedman DL, Ambinder RF) Blood Adv 2017 Apr 25;1(11):681-684 PMID: 29296710 PMCID: PMC5727814 SCOPUS ID: 2-s2.0-85040967527 01/04/2018 35 Citations

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. (Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM) Cancer 2018 Jan 01;124(1):136-144 PMID: 28902390 PMCID: PMC5735034 SCOPUS ID: 2-s2.0-85029357188 09/14/2017 56 Citations

Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group. (Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE) Pediatr Blood Cancer 2018 Jan;65(1) PMID: 28802087 PMCID: PMC5699946 SCOPUS ID: 2-s2.0-85035072987 08/13/2017 22 Citations

Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report. (Fernández KS, Schwartz CL, Chen L, Constine LS, Chauvenet A, de Alarcón PA) Pediatr Blood Cancer 2017 Dec;64(12) PMID: 28612375 PMCID: PMC5799083 SCOPUS ID: 2-s2.0-85020674164 06/15/2017 18 Citations

Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia. (Esbenshade AJ, Zhao Z, Aftandilian C, Saab R, Wattier RL, Beauchemin M, Miller TP, Wilkes JJ, Kelly MJ, Fernbach A, Jeng M, Schwartz CL, Dvorak CC, Shyr Y, Moons KGM, Sulis ML, Friedman DL) Cancer 2017 Oct 01;123(19):3781-3790 PMID: 28542918 PMCID: PMC5610619 SCOPUS ID: 2-s2.0-85029832642 05/26/2017 24 Citations

Understanding predictors of continued long-term pediatric cancer care across the region: A report from the Consortium for New England Childhood Cancer Survivors. (Welch JJG, Kenney LB, Hirway P, Usmani GN, Kadan-Lottick N, Grewal SS, Huang M, Bradeen H, Ader J, Diller L, Schwartz CL) Pediatr Blood Cancer 2017 Oct;64(10) PMID: 28453181 SCOPUS ID: 2-s2.0-85018305826 04/30/2017 15 Citations

Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease. (Harrison DJ, Schwartz CL) Curr Treat Options Oncol 2017 Apr;18(4):24 PMID: 28391422 SCOPUS ID: 2-s2.0-85017164334 04/10/2017 60 Citations

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial. (Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC) Int J Radiat Oncol Biol Phys 2016 Dec 01;96(5):943-950 PMID: 27869096 PMCID: PMC5584603 SCOPUS ID: 2-s2.0-85004074793 11/22/2016 23 Citations

Mental distress and health care use among survivors of adolescent and young adult cancer: A cross-sectional analysis of the National Health Interview Survey. (Kaul S, Avila JC, Mutambudzi M, Russell H, Kirchhoff AC, Schwartz CL) Cancer 2017 Mar 01;123(5):869-878 PMID: 27859009 SCOPUS ID: 2-s2.0-85002809108 11/20/2016 103 Citations

Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL) Pediatr Blood Cancer 2017 Apr;64(4) PMID: 27786406 PMCID: PMC5702912 SCOPUS ID: 2-s2.0-84999035250 10/28/2016 58 Citations

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. (Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS) Lancet Oncol 2016 Oct;17(10):1396-1408 PMID: 27569442 PMCID: PMC5052459 SCOPUS ID: 2-s2.0-84992374798 08/30/2016 504 Citations

Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group. (Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL) J Clin Oncol 2016 Jul 10;34(20):2372-9 PMID: 27185849 PMCID: PMC4981978 SCOPUS ID: 2-s2.0-84977577007 05/18/2016 78 Citations

Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee. (Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ) Pediatr Blood Cancer 2016 Oct;63(10):1737-43 PMID: 27128693 PMCID: PMC5136499 SCOPUS ID: 2-s2.0-84983331676 04/30/2016 51 Citations

Pediatric hodgkin lymphoma (Hall GW, Schwartz CL, Daw S, Constine LS) Hematologic Malignancies 1 December 2015;6:253-270 SCOPUS ID: 2-s2.0-84965065063 12/01/2015

Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group. (Macpherson CF, Hooke MC, Friedman DL, Campbell K, Withycombe J, Schwartz CL, Kelly K, Meza J) J Adolesc Young Adult Oncol 2015 Sep;4(3):137-40 PMID: 26421221 PMCID: PMC4575513 SCOPUS ID: 2-s2.0-85006189376 10/01/2015 11 Citations

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. (Schwartz CL, Wexler LH, Krailo MD, Teot LA, Devidas M, Steinherz LJ, Goorin AM, Gebhardt MC, Healey JH, Sato JK, Meyers PA, Grier HE, Bernstein ML, Lipshultz SE) Pediatr Blood Cancer 2016 Jan;63(1):54-61 PMID: 26398490 PMCID: PMC4779061 SCOPUS ID: 2-s2.0-84983208745 09/24/2015 88 Citations

Algorithms of late effects by disease (Schwartz CL, Hobbie WL, Constine LS) Survivors of Childhood and Adolescent Cancer A Multidisciplinary Approach Third Edition 3 September 2015:1-13 SCOPUS ID: 2-s2.0-85025092779 09/03/2015 1 Citation

Facilitating assessment of late effects by organ system (Schwartz CL, Hobbie WL, Constine LS) Survivors of Childhood and Adolescent Cancer A Multidisciplinary Approach Third Edition 3 September 2015:15-32 SCOPUS ID: 2-s2.0-85025087418 09/03/2015

Pulmonary effects of antineoplastic therapy (Dhakal S, Weiner D, Schwartz C, Constine LS) Survivors of Childhood and Adolescent Cancer A Multidisciplinary Approach Third Edition 3 September 2015:201-227 SCOPUS ID: 2-s2.0-85025098176 09/03/2015 1 Citation

Survivors of childhood and adolescent cancer: A multidisciplinary approach: Third Edition (Schwartz CL, Hobbie WL, Constine LS, Ruccione KS) Survivors of Childhood and Adolescent Cancer A Multidisciplinary Approach Third Edition 3 September 2015:1-436 SCOPUS ID: 2-s2.0-85025096358 09/03/2015 9 Citations

The thyroid gland (Milano MT, Dhakal S, Schwartz CL, Constine LS) Survivors of Childhood and Adolescent Cancer A Multidisciplinary Approach Third Edition 3 September 2015:151-166 SCOPUS ID: 2-s2.0-85025084772 09/03/2015

Pediatric Hodgkin Lymphoma. (Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, Körholz D) J Clin Oncol 2015 Sep 20;33(27):2975-85 PMID: 26304892 SCOPUS ID: 2-s2.0-84942274989 08/26/2015 182 Citations

Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group. (Chow EJ, Asselin BL, Schwartz CL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH) J Clin Oncol 2015 Aug 20;33(24):2639-45 PMID: 26014292 PMCID: PMC4534526 SCOPUS ID: 2-s2.0-84940502191 05/28/2015 90 Citations

A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study. (Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, López-Terrada D, Mrazek MD, Agrawal N, Wu MF, Liu H, De Alarcon PA, Trippet TM, Schwartz CL) Br J Haematol 2015 Jul;170(1):118-22 PMID: 25833390 PMCID: PMC4478135 SCOPUS ID: 2-s2.0-84931563104 04/03/2015 26 Citations

Radiotherapy quality assurance report from children's oncology group AHOD0031. (Dharmarajan KV, Friedman DL, FitzGerald TJ, McCarten KM, Constine LS, Chen L, Kessel SK, Iandoli M, Laurie F, Schwartz CL, Wolden SL) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):1065-71 PMID: 25670539 PMCID: PMC5240783 SCOPUS ID: 2-s2.0-84925351290 02/12/2015 18 Citations

Survivorship. (Harrison DJ, Schwartz C) J Surg Oncol 2015 Apr;111(5):648-55 PMID: 25557722 SCOPUS ID: 2-s2.0-84925425829 01/06/2015 9 Citations

Facilitating assessment of late effects by organ system (Schwartz CL, Hobbie WL, Constine LS) Pediatric Oncology 2015;2015:15-32 SCOPUS ID: 2-s2.0-84976565139 01/01/2015

Algorithms of late effects by disease (Schwartz CL, Hobbie WL, Constine LS) Pediatric Oncology 2015;2015:1-13 SCOPUS ID: 2-s2.0-84976545023 01/01/2015

Pulmonary effects of antineoplastic therapy (Dhakal S, Weiner D, Schwartz C, Constine LS) Pediatric Oncology 2015;2015:201-227 SCOPUS ID: 2-s2.0-84976553737 01/01/2015 3 Citations

The thyroid gland (Milano MT, Dhakal S, Schwartz CL, Constine LS) Pediatric Oncology 2015;2015:151-166 SCOPUS ID: 2-s2.0-84976543678 01/01/2015

Pediatric hodgkin lymphoma (Hall GW, Schwartz CL, Daw S, Constine LS) Hodgkin Lymphoma A Comprehensive Overview Second Edition 1 January 2015:253-270 SCOPUS ID: 2-s2.0-84955703611 01/01/2015

Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. (Dharmarajan KV, Friedman DL, Schwartz CL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL) Int J Radiat Oncol Biol Phys 2015 May 01;92(1):60-6 PMID: 25542311 PMCID: PMC4395527 SCOPUS ID: 2-s2.0-84927571861 12/30/2014 26 Citations

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. (Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, Schwartz CL) J Clin Oncol 2014 Nov 10;32(32):3651-8 PMID: 25311218 PMCID: PMC4220044 SCOPUS ID: 2-s2.0-84911866817 10/15/2014 245 Citations

Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. (Trippett TM, Schwartz CL, Guillerman RP, Gamis AS, Gardner S, Hogan S, London WB, Chen L, de Alarcon P) Pediatr Blood Cancer 2015 Jan;62(1):60-4 PMID: 25308760 PMCID: PMC4465390 SCOPUS ID: 2-s2.0-84922830869 10/14/2014 27 Citations

HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. (Gorlick S, Barkauskas DA, Krailo M, Piperdi S, Sowers R, Gill J, Geller D, Randall RL, Janeway K, Schwartz C, Grier H, Meyers PA, Gorlick R, Bernstein M, Marina N) Pediatr Blood Cancer 2014 Sep;61(9):1558-64 PMID: 24753182 PMCID: PMC4288578 SCOPUS ID: 2-s2.0-84904431182 04/23/2014 21 Citations

ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. (Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS) Pediatr Blood Cancer 2014 Jul;61(7):1305-12 PMID: 24616347 SCOPUS ID: 2-s2.0-84899686109 03/13/2014 17 Citations

Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study. (Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA) Pediatr Blood Cancer 2014 Apr;61(4):749-52 PMID: 24178953 PMCID: PMC3946315 SCOPUS ID: 2-s2.0-84893451918 11/02/2013 11 Citations

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group. (Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Schwartz C, Chauvenet A) Pediatr Blood Cancer 2012 Dec 15;59(7):1259-65 PMID: 22911615 PMCID: PMC3468662 SCOPUS ID: 2-s2.0-84867375691 08/23/2012 82 Citations

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. (Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL) J Clin Oncol 2012 Jul 20;30(21):2635-40 PMID: 22689804 PMCID: PMC4559601 SCOPUS ID: 2-s2.0-84864072818 06/13/2012 75 Citations

Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group. (Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N) Cancer 2012 Sep 15;118(18):4597-605 PMID: 22252521 PMCID: PMC4008337 SCOPUS ID: 2-s2.0-84862837194 01/19/2012 170 Citations

The current status of follow-up services for childhood cancer survivors, are we meeting goals and expectations: a report from the Consortium for New England Childhood Cancer Survivors. (Kenney LB, Bradeen H, Kadan-Lottick NS, Diller L, Homans A, Schwartz CL) Pediatr Blood Cancer 2011 Dec 01;57(6):1062-6 PMID: 21910208 SCOPUS ID: 2-s2.0-80052686295 09/13/2011 35 Citations

ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II. (Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ) J Am Coll Radiol 2011 May;8(5):302-8 PMID: 21531305 SCOPUS ID: 2-s2.0-84928099360 05/03/2011 2 Citations

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. (Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Schwartz CL, Cohen HJ, Lipshultz SE, Silverman LB, Sallan SE) Eur J Cancer 2011 Jun;47(9):1373-9 PMID: 21514146 PMCID: PMC3736806 SCOPUS ID: 2-s2.0-79957557043 04/26/2011 111 Citations

Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report. (Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Schwartz CL) Pediatr Hematol Oncol 2010 Nov;27(8):650-7 PMID: 20863157 PMCID: PMC3083978 SCOPUS ID: 2-s2.0-77958051538 09/25/2010 2 Citations

Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. (Loeb DM, Hobbs RF, Okoli A, Chen AR, Cho S, Srinivasan S, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL) Cancer 2010 Dec 01;116(23):5470-8 PMID: 20715156 PMCID: PMC2991401 SCOPUS ID: 2-s2.0-78649594834 08/18/2010 22 Citations

ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. (Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ) Curr Probl Cancer 2010;34(3):211-27 PMID: 20541059 SCOPUS ID: 2-s2.0-77953100953 06/15/2010 33 Citations

Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498). (Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye J, Vikram B, Friedman D, Marcus RB Jr, Mendenhall NP, Williams JL, Purdy J, Saltz J, Schwartz CL, White KS, Wolden S) Int J Radiat Oncol Biol Phys 2010 May 01;77(1):315-6 PMID: 20394859 PMCID: PMC2908913 SCOPUS ID: 2-s2.0-77950590364 04/17/2010 9 Citations

Hodgkin lymphoma in children (Friedman DL, Schwartz CL) Lymphoid Neoplasms 3ed 1 January 2010:1279-1298 SCOPUS ID: 2-s2.0-85056061109 01/01/2010 1 Citation

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). (Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, Schwartz CL, O'Holleran EW, Neuberg DS, Cohen HJ, Sallan SE) Leukemia 2010 Feb;24(2):320-34 PMID: 20016537 PMCID: PMC2820141 SCOPUS ID: 2-s2.0-76749108502 12/18/2009 282 Citations

Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. (Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, Schwartz CL, O'Brien JE, Cohen HJ, Sallan SE) Blood 2010 Feb 18;115(7):1351-3 PMID: 20007809 PMCID: PMC2826760 SCOPUS ID: 2-s2.0-77949895397 12/17/2009 96 Citations

Bacteremia in febrile nonneutropenic pediatric oncology patients. (Kelly MJ, Vivier PM, Panken TM, Schwartz CL) Pediatr Blood Cancer 2010 Jan;54(1):83-7 PMID: 19774640 SCOPUS ID: 2-s2.0-73349107163 09/24/2009 28 Citations

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. (Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A) Blood 2009 Sep 03;114(10):2051-9 PMID: 19584400 PMCID: PMC2744567 SCOPUS ID: 2-s2.0-70349260655 07/09/2009 212 Citations

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. (Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD Jr, Scott T, Schwartz CL) Cancer 2009 Jun 01;115(11):2514-22 PMID: 19338063 PMCID: PMC2974628 SCOPUS ID: 2-s2.0-66649106084 04/02/2009 48 Citations

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. (Cole PD, Schwartz CL, Drachtman RA, de Alarcon PA, Chen L, Trippett TM) J Clin Oncol 2009 Mar 20;27(9):1456-61 PMID: 19224841 PMCID: PMC2668553 SCOPUS ID: 2-s2.0-63049134801 02/20/2009 56 Citations

Parental needs for information related to neurocognitive late effects from pediatric cancer and its treatment. (Trask CL, Welch JJ, Manley P, Jelalian E, Schwartz CL) Pediatr Blood Cancer 2009 Feb;52(2):273-9 PMID: 18985741 SCOPUS ID: 2-s2.0-59449090167 11/06/2008 25 Citations

In reply (Meyers PA, Schwartz CL, Krailo MD, Healey JH, Ferguson WS, Gebhardt MC, Goorin AM, Kleinerman ES, Nieder ML, Wells RJ, Sato JK, Grier HE) Journal of Clinical Oncology 2008;26(18):3104-3105 SCOPUS ID: 2-s2.0-51349105815 09/15/2008 3 Citations

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. (Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):24-33 PMID: 18722263 PMCID: PMC3531236 SCOPUS ID: 2-s2.0-49549115762 08/30/2008 127 Citations

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. (Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS) Int J Radiat Oncol Biol Phys 2008 Sep 01;72(1):34-40 PMID: 18722264 PMCID: PMC3532026 SCOPUS ID: 2-s2.0-49549105338 08/30/2008 54 Citations

Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma. (Lucas KG, Schwartz C, Kaplan J) Pediatr Blood Cancer 2008 Jul;51(1):142-4 PMID: 18266223 SCOPUS ID: 2-s2.0-44149103165 02/13/2008 26 Citations

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. (Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE, Children's Oncology Group) J Clin Oncol 2008 Feb 01;26(4):633-8 PMID: 18235123 SCOPUS ID: 2-s2.0-39149136228 02/01/2008 707 Citations

In reply [4] (Carver JR, Jacobs LA, Vaughn DJ, Shapiro CL, Ng A, Virgo KS, Hagerty K, Somerfield MR, Schwartz CL) Journal of Clinical Oncology 1 January 2008;26(1):162 SCOPUS ID: 2-s2.0-37849018745 01/01/2008

In reply [10] (Schwartz CL, Gorlick R, Teot L, Krailo M, Goorin A, Grier HE, Bernstein ML, Meyers P) Journal of Clinical Oncology 20 October 2007;25(30):4860-4861 SCOPUS ID: 2-s2.0-36049015453 10/20/2007

In reply [2] (Schwartz CL, Constine LS, London WB, Sposto R, Friedman DL, Tebbi CK, Mendenhall N, Chen AR, De Alarcon PA, Villaluna D, Chauvenet AR) Journal of Clinical Oncology 10 October 2007;25(29):4690-4691 SCOPUS ID: 2-s2.0-35649026367 10/10/2007 3 Citations

Orthostatic intolerance in survivors of childhood cancer. (Terlou A, Ruble K, Stapert AF, Chang HC, Rowe PC, Schwartz CL) Eur J Cancer 2007 Dec;43(18):2685-90 PMID: 17689953 SCOPUS ID: 2-s2.0-36348964796 08/11/2007 5 Citations

Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. (Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ) Antimicrob Agents Chemother 2007 Oct;51(10):3714-9 PMID: 17638696 PMCID: PMC2043253 SCOPUS ID: 2-s2.0-34948887165 07/20/2007 102 Citations

In reply [2] (Schwartz CL, Constine LS, London WB, Sposto R, Friedman D, Tebbi CK, Mendenhall NP, Villaluna D, De Alarcon PA, Chauvenet A) Journal of Clinical Oncology 20 July 2007;25(21):3180 SCOPUS ID: 2-s2.0-34547696923 07/20/2007 1 Citation

American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. (Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ, ASCO Cancer Survivorship Expert Panel) J Clin Oncol 2007 Sep 01;25(25):3991-4008 PMID: 17577017 SCOPUS ID: 2-s2.0-34548522479 06/20/2007 706 Citations

Motor and perceptual timing deficits among survivors of childhood leukemia. (Mahone EM, Prahme MC, Ruble K, Mostofsky SH, Schwartz CL) J Pediatr Psychol 2007 Sep;32(8):918-25 PMID: 17522113 SCOPUS ID: 2-s2.0-36649002697 05/25/2007 16 Citations

Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. (Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A, Grier HE, Bernstein ML, Meyers P, Children's Oncology Group) J Clin Oncol 2007 May 20;25(15):2057-62 PMID: 17513810 SCOPUS ID: 2-s2.0-34249936286 05/22/2007 119 Citations

Monitoring diagnostic accuracy and complications. A report from the Children's Oncology Group Hodgkin lymphoma study. (Ehrlich PF, Friedman DL, Schwartz CL, Children Oncology Group Hodgkin Lymphoma study section) J Pediatr Surg 2007 May;42(5):788-91 PMID: 17502184 SCOPUS ID: 2-s2.0-34248138556 05/16/2007 17 Citations

Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma. (Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ) Pediatr Blood Cancer 2008 Mar;50(3):667-70 PMID: 17318876 SCOPUS ID: 2-s2.0-38549129707 02/24/2007 23 Citations

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. (Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL) J Clin Oncol 2007 Feb 10;25(5):493-500 PMID: 17290056 SCOPUS ID: 2-s2.0-33947542048 02/10/2007 473 Citations

Chronic health conditions in adult survivors of childhood cancer. (Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL, Childhood Cancer Survivor Study) N Engl J Med 2006 Oct 12;355(15):1572-82 PMID: 17035650 SCOPUS ID: 2-s2.0-33749599695 10/13/2006 3271 Citations

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. (Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR, Children's Oncology Group) J Pediatr Hematol Oncol 2006 Jun;28(6):362-8 PMID: 16794504 SCOPUS ID: 2-s2.0-33745677279 06/24/2006 84 Citations

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. (Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA) Antimicrob Agents Chemother 2005 Nov;49(11):4536-45 PMID: 16251293 PMCID: PMC1280172 SCOPUS ID: 2-s2.0-27644585388 10/28/2005 218 Citations

Sm-153 EDTMP for recurrent metastatic osteosarcoma. (Welsh JS, Thurman SA, Borzillary S, Schwartz CL, Howard SP) Clin Adv Hematol Oncol 2003 Mar;1(3):181-3; discussion 183 PMID: 16224400 SCOPUS ID: 2-s2.0-0344149671 10/15/2005 4 Citations

APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial. (Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL) Pediatr Blood Cancer 2006 Mar;46(3):320-4 PMID: 16200630 SCOPUS ID: 2-s2.0-32044471088 10/04/2005 9 Citations

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. (Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ) Antimicrob Agents Chemother 2005 Aug;49(8):3317-24 PMID: 16048942 PMCID: PMC1196271 SCOPUS ID: 2-s2.0-23044445767 07/29/2005 218 Citations

Special issues in pediatric Hodgkin's disease. (Schwartz CL) Eur J Haematol Suppl 2005 Jul(66):55-62 PMID: 16007870 SCOPUS ID: 2-s2.0-21044459649 07/13/2005 28 Citations

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. (Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier H) J Clin Oncol 2005 Mar 20;23(9):2004-11 PMID: 15774791 SCOPUS ID: 2-s2.0-20144380941 03/19/2005 686 Citations

Health status of adult long-term survivors of childhood cancer:a report from the Childhood Cancer Survivor Study. (Schwartz CL) J Pediatr 2004 Mar;144(3):407-8 PMID: 15032224 03/23/2004

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. (Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B) Clin Cancer Res 2003 Nov 15;9(15):5442-53 PMID: 14654523 SCOPUS ID: 2-s2.0-0344198135 12/05/2003 174 Citations

Prognostic factors in pediatric Hodgkin disease. (Schwartz CL) Curr Oncol Rep 2003 Nov;5(6):498-504 PMID: 14521809 SCOPUS ID: 2-s2.0-2442482680 10/03/2003 14 Citations

Health status of childhood cancer survivors: cure is more than the eradication of cancer. (Schwartz CL) JAMA 2003 Sep 24;290(12):1641-3 PMID: 14506124 SCOPUS ID: 2-s2.0-0141461840 09/25/2003 27 Citations

Radiation-associated cardiovascular disease: manifestations and management. (Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS) Semin Radiat Oncol 2003 Jul;13(3):346-56 PMID: 12903022 SCOPUS ID: 2-s2.0-0042527694 08/07/2003 204 Citations

The management of Hodgkin disease in the young child. (Schwartz CL) Curr Opin Pediatr 2003 Feb;15(1):10-6 PMID: 12544266 SCOPUS ID: 2-s2.0-0037305984 01/25/2003 31 Citations

Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. (Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM) J Med Virol 2002 Nov;68(3):370-7 PMID: 12226824 SCOPUS ID: 2-s2.0-0036836520 09/13/2002 33 Citations

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S) Transfus Med Rev 2002 Jan;16(1):34-45 PMID: 11788928 SCOPUS ID: 2-s2.0-0036141153 01/15/2002 129 Citations

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. (Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE) J Clin Oncol 2002 Jan 15;20(2):426-33 PMID: 11786570 SCOPUS ID: 2-s2.0-0037080289 01/12/2002 212 Citations

Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry. (Lipton JM, Federman N, Khabbaze Y, Schwartz CL, Hilliard LM, Clark JI, Vlachos A, Diamond-Black Anemia Registry) J Pediatr Hematol Oncol 2001 Jan;23(1):39-44 PMID: 11196268 SCOPUS ID: 2-s2.0-0035129306 02/24/2001 116 Citations

Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. (Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, Sallan SE) J Clin Oncol 2001 Feb 15;19(4):1040-6 PMID: 11181667 SCOPUS ID: 2-s2.0-0035865159 02/22/2001 54 Citations

Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. (Spunt SL, Lobe TE, Pappo AS, Parham DM, Wharam MD Jr, Arndt C, Anderson JR, Crist WM, Paidas C, Wiener E, Andrassy RJ, Schwartz CL) J Pediatr Surg 2000 Feb;35(2):309-16 PMID: 10693686 SCOPUS ID: 2-s2.0-12944273553 02/29/2000 129 Citations

Long-term survivors of childhood cancer: the late effects of therapy. (Schwartz CL) Oncologist 1999;4(1):45-54 PMID: 10337370 SCOPUS ID: 2-s2.0-0032997716 05/25/1999 158 Citations

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. (Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS) N Engl J Med 1999 Mar 11;340(10):764-71 PMID: 10072411 SCOPUS ID: 2-s2.0-0033545538 03/11/1999 1172 Citations

Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. (Leung W, Chen AR, Klann RC, Moss TJ, Davis JM, Noga SJ, Cohen KJ, Friedman AD, Small D, Schwartz CL, Borowitz MJ, Wharam MD, Paidas CN, Long CA, Karandish S, McMannis JD, Kastan MB, Civin CI) Bone Marrow Transplant 1998 Nov;22(10):971-9 PMID: 9849694 SCOPUS ID: 2-s2.0-0031723262 12/16/1998 63 Citations

Osteosarcoma. (Dome JS, Schwartz CL) Cancer Treat Res 1997;92:215-51 PMID: 9494763 SCOPUS ID: 2-s2.0-0031297856 01/01/1997 12 Citations

NCCN pediatric osteosarcoma practice guidelines. The National Comprehensive Cancer Network. (O'Reilly R, Link M, Fletcher B, Gebhardt M, Krance R, Meyers P, Neff J, Schwartz C) Oncology (Williston Park) 1996 Dec;10(12):1799-806, 1812 PMID: 8985965 SCOPUS ID: 2-s2.0-0030463691 12/01/1996 7 Citations

Intermittent high-dose deferoxamine for patients with iron overload and sickle cell anemia (Korones DN, Weidner S, Schwartz CL) International Journal of Pediatric Hematology Oncology 1996;3(1):53-56 SCOPUS ID: 2-s2.0-0029983044 01/01/1996

Late effects of treatment in long-term survivors of cancer. (Schwartz CL) Cancer Treat Rev 1995 Jul;21(4):355-66 PMID: 7585660 SCOPUS ID: 2-s2.0-0028859444 07/01/1995 43 Citations

Multiple drug resistance in osteosarcoma. (Rosier RN, Teot LA, Hicks DG, Schwartz C, O'Keefe RJ, Puzas JE) Iowa Orthop J 1995;15:66-73 PMID: 7634047 PMCID: PMC2329065 SCOPUS ID: 2-s2.0-0029185462 01/01/1995 7 Citations

Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. (Schwartz CL, Hobbie WL, Truesdell S, Constine LC, Clark EB) J Clin Oncol 1993 Oct;11(10):1906-10 PMID: 8410117 SCOPUS ID: 2-s2.0-0027367249 10/01/1993 96 Citations

Transposition of the oncogene ets-1 in t(11;19) translocation in acute leukemia. (Wang N, Cedrone E, Dry J, Skuse GR, Schwartz C, Terryberry S) Cancer Genet Cytogenet 1990 Dec;50(2):199-205 PMID: 2265401 SCOPUS ID: 2-s2.0-0025599801 12/01/1990 2 Citations

Creating life on the plateau: reproductive potential in survivors of childhood Hodgkin's disease. (Schwartz CL) Int J Radiat Oncol Biol Phys 1990 Oct;19(4):1099-100 PMID: 2211248 SCOPUS ID: 2-s2.0-0025007216 10/01/1990 2 Citations

Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. (Schwartz C, Henrickson KJ, Roghmann K, Powell K) J Clin Oncol 1990 Sep;8(9):1591-7 PMID: 2202792 SCOPUS ID: 2-s2.0-0025003394 09/01/1990 191 Citations

Creating life on the plateau: Reproductive potential in survivors of childhood Hodgkin's disease (Schwartz CL) Int J Rad Onc Biol Phys (19):1099-1100 08/16/1990

Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheter with vancomycin susceptible organisms. (Schwartz CL, Henrickson KJ, Roghmann K, Powell K.) J Clin Oncol (8):1591-1597 06/27/1990

Still more on Tufts' student surgery program. J Am Vet Med Assoc 1990 Apr 01;196(7):1002-3, 1006 PMID: 2329065 SCOPUS ID: 2-s2.0-0025409025 04/01/1990

To the editor (I: Reply) (Schwartz CL, Miller NR, Wharam MD, Leventhal BG) Cancer 1990;65(6):1462 SCOPUS ID: 2-s2.0-0025239831 01/01/1990 1 Citation

Letter to the editor (Rohr LR, Koss LG, Nitschke R, Schwartz CL, Miller NR, Wharam MD, Leventhal BG) Cancer 15 March 1990;65(6):1460-1462 SCOPUS ID: 2-s2.0-85005176139 01/01/1990

The optic nerve as the site of initial relapse in childhood acute lymphoblastic leukemia. (Schwartz CL, Miller NR, Wharam MD, Leventhal BG) Cancer 1989 Apr 15;63(8):1616-20 PMID: 2635874 SCOPUS ID: 2-s2.0-0024524377 04/15/1989 32 Citations

Endocrine late effects among survivors of cancer. (Hobbie WL, Schwartz CL) Semin Oncol Nurs 1989 Feb;5(1):14-21 PMID: 2646663 SCOPUS ID: 2-s2.0-0024618817 02/01/1989 4 Citations

Preleukemic syndromes and other syndromes predisposing to leukemia. (Schwartz CL, Cohen HJ) Pediatr Clin North Am 1988 Aug;35(4):853-71 PMID: 3047657 SCOPUS ID: 2-s2.0-0023791379 08/01/1988 10 Citations

A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities. (Henrickson KJ, Powell KR, Schwartz CL) J Infect Dis 1988 Mar;157(3):600-1 PMID: 3343531 SCOPUS ID: 2-s2.0-0023946994 03/01/1988 30 Citations

Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. (Schwartz CL, Minniti CP, Harwood P, Na S, Banquerigo ML, Strauss LC, Kurtzberg J, Smith SD, Civin CI) J Clin Oncol 1987 Dec;5(12):1900-11 PMID: 3500279 SCOPUS ID: 2-s2.0-0023521490 12/01/1987 5 Citations

Rapid separation of whole human bone marrow aspirates by counterflow centrifugation elutriation. (Noga SJ, Schwartz CL, Civin CI, Loken M, Donnenberg AD) Transplantation 1987 Mar;43(3):438-40 PMID: 3547800 SCOPUS ID: 2-s2.0-0023131021 03/01/1987 6 Citations

Large scale separation of human bone marrow by counterflow centrifugation elutriation. (Noga SJ, Cremo CA, Duff SC, Schwartz CL, Melaragno A, Civin CI, Donnenberg AD) J Immunol Methods 1986 Sep 27;92(2):211-8 PMID: 2944969 SCOPUS ID: 2-s2.0-0022479857 09/27/1986 13 Citations

Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow. (Noga SJ, Donnenberg AD, Schwartz CL, Strauss LC, Civin CI, Santos GW) Transplantation 1986 Feb;41(2):220-9 PMID: 2935979 SCOPUS ID: 2-s2.0-0022650754 02/01/1986 38 Citations

QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine. (Schwartz CL, Bender KS, Burke PJ, Kan JS, Civin CI) Cancer Treat Rep 1984;68(7-8):1043-4 PMID: 6547639 SCOPUS ID: 2-s2.0-0021183523 07/01/1984 6 Citations

Last update: 09/17/2026

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty

Cindy L. Schwartz MD, MPH

Professor

Publications (153)